Korean J Anesthesiol.  2000 Apr;38(4):663-669. 10.4097/kjae.2000.38.4.663.

L2-3 versus T12-L1 Administration of Meperidine and Bupivacaine Using Patient-Controlled Epidural Analgesia after Obstetric and Gynecologic Surgery

Affiliations
  • 1Depertment of Anesthesiology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

BACKGROUND: A combined administration of epidural opioid and local anesthetic using patient- controlled epidural analgesia (PCEA) produces effective postoperative analgesia, but often causes profound motor and sensory blockade. The purpose of this study is to investigate the effect the location of the catheter insertion site has on total dose requirements and troublesome side effects including motor and sensory blockade after surgery.
METHODS
140 patients who had undergone obstetric and gynecologic surgery were randomly assigned to receive either L2-3 (Group L2-3) or T12-L1 (Group T12-L1) epidural catheter. All patients received meperidine and bupivacaine by PCEA. Patients were assessed with respect to total dose requirements, visual analogue scores and side effects.
RESULTS
Total dose requirements, motor and sensory blocks were significantly lower in group T12-L1 compared with group L2-3. There were no significant differences in VAS, pruritus, nausea/vomiting, or patient's satisfaction.
CONCLUSIONS
When the epidural placement level is closer to the dermatomes of the surgical incision in lower abdominal surgery, the total dose requirements can be reduced, and motor blocks that interfere with early ambulation and sensory block can also be reduced.

Keyword

Analgesia: epidural; patient-controlled; Analgesics: bupivacaine; meperidine; Pain: postoperative

MeSH Terms

Analgesia
Analgesia, Epidural*
Bupivacaine*
Catheters
Early Ambulation
Female
Gynecologic Surgical Procedures*
Humans
Meperidine*
Pruritus
Bupivacaine
Meperidine
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr